TP53 and renal cell carcinoma: They identified derivatives of 9-aminoacridine (9AA, Fig. 9G), including the antimalaria drug quinacrine (QC, Fig. 9H), which strongly induced p53 function in RCC as well as in other types of cancer cells [143].